Investigations start into deaths of people given the Covid vaccine

Please share this story - thanks

Just two weeks into the roll out of a handful of different Covid-19 vaccines and reports are emerging of a possible link between the treatment and subsequent deaths of vaccinated people – including a doctor.

In Norway the authorities are investigating the deaths of two nursing home residents who received the Pfizer and BioNTech vaccine.

Medical Director of Norwegian Medicines Agency Steiner Madsen said in a statement: ”We have to assess whether the vaccine is the cause of death, or if it is a coincidence that it happened soon after vaccination.”

The agency along with Norway’s National Institute of Public Health are looking into cause the deaths.


According to USA Today an otherwise perfectly healthy doctor died within days of being vaccinated.

Dr. Gregory Michael, 56, an OB-GYN at Mount Sinai Medical Center in Miami Beach, died after suffering a hemorrhagic stroke apparently resulting from a lack of platelets.

Miami medical examiners are investigating his death, the Florida Department of Health said in a statement.

Pfizer, which along with its partner BioNTech made the vaccine the man received, says it is aware of the death.

“We are actively investigating this case, but we don’t believe at this time that there is any direct connection to the vaccine,” the statement said.

In a Facebook post, Michael’s wife, Heidi Neckelmann, blamed his death on the vaccine.

She said a team of doctors from across the country (USA) tried for two weeks to raise his platelet count “to no avail”.

He was conscious until suffering a hemorrhagic stroke “that took his life in a matter of minutes,” she wrote.

Michael was a vaccine advocate, his wife said, before raising doubts about its safety.


In Switzerland a 91-year-old died after being given the Covid vaccine.

Website SwissMedic reports that “A few days after receiving a vaccination against COVID-19, a 91-year-old person with multiple serious pre-existing health conditions died at a retirement home in Canton Lucerne.

“Neither the person’s medical history nor the acute course of their illness suggests a direct causal link between the COVID-19 vaccination and their death.”

In this latest case it is worth noting that this elderly person apparently did not die of (or with) Covid-19.


Then there is the mystery of a 42-year-old in India – Deepak Marawi – who died 10 days after being given a Covid-19 vaccination, but apparently died of poisoning.

According to a report in the Hindustan Times: “Dr Rajesh Kapur, Vice Chancellor, People’s Medical College and Hospital where the trial was conducted, told PTI that Deepak Marawi had participated in the Covaxin trial held on December 12, 2020.

“Madhya Pradesh Medico Legal Institute Director Dr Ashok Sharma said the doctor who had performed postmortem of the deceased suspects that he died of poisoning.”

Poisoned with what we wonder.


And let’s not forget the vaccine volunteer who died in October 2020.

According to the New Zealand Herald a volunteer taking part in human trials for the University of Oxford’s Covid-19 vaccine died “sparking concern and confusion over the circumstances surrounding his death”.

The man has been named as 28-year-old doctor João Pedro R. Feitosa from Brazil, and according to one report had been given a placebo. However, the ‘placebo’ in this case was not an inert substance, but a meningitis vaccine (according to news agency Reuters), which in our opinion is not a placebo.

The doctor’s official cause of death is listed as “complications due to Covid-19”.

Herd immunity?

Elsewhere, NZ Blood Service (NZBS) is calling for Convalescent Plasma donations from those who have recovered from COVID-19.

The organisation says it is collecting convalescent plasma from those who have recovered from COVID-19, to help in the treatment of COVID-19 patients.

In a statement NZBS says: “Convalescent plasma is collected from patients who have recently recovered from an illness that stimulates the patient’s immune system into producing high levels of antibodies directed specifically against the illness. These antibodies can be collected and transfused to provide a level of immunity against the illness in patients who have not yet recovered.

“Convalescent plasma was first recorded in the 1880s with animal cases showing protection against diphtheria and tetanus, leading to significant clinical use from the 1920s. After World War II, its use dropped off with the discovery of various antibiotics. But in recent years, it has been used against SARS, H1N1 influenza and Ebola. Recent studies have indicated that patients with COVID-19 may respond to convalescent plasma.”

Please share this story - thanks